MS Pharma Partners With Mabxience For Bevacizumab In MENA Region

Follows Agreement With Alvion For Rosuvastatin/Ezetimibe In MENA

 
• By Akriti Seth
  
MENA
MS Pharma is ready to commercialize bevacizumab and rosuvastatin/ezetimibe in the Middle East and North Africa region • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products